Retirement Systems of Alabama lowered its stake in shares of Allergan PLC. (NYSE:AGN) by 0.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 271,192 shares of the company’s stock after selling 655 shares during the period. Retirement Systems of Alabama owned 0.08% of Allergan PLC. worth $55,581,000 at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. Pathstone Family Office LLC raised its stake in Allergan PLC. by 3,327.3% in the 2nd quarter. Pathstone Family Office LLC now owns 377 shares of the company’s stock valued at $2,035,000 after acquiring an additional 366 shares during the period. Howard Hughes Medical Institute bought a new stake in Allergan PLC. in the 2nd quarter valued at $103,000. Jacobi Capital Management LLC raised its stake in Allergan PLC. by 4.9% in the 1st quarter. Jacobi Capital Management LLC now owns 472 shares of the company’s stock valued at $112,000 after acquiring an additional 22 shares during the period. Massey Quick & Co. LLC raised its stake in Allergan PLC. by 334.8% in the 2nd quarter. Massey Quick & Co. LLC now owns 500 shares of the company’s stock valued at $122,000 after acquiring an additional 385 shares during the period. Finally, Cable Hill Partners LLC raised its stake in Allergan PLC. by 255.2% in the 3rd quarter. Cable Hill Partners LLC now owns 515 shares of the company’s stock valued at $106,000 after acquiring an additional 370 shares during the period. Institutional investors own 81.21% of the company’s stock.
Allergan PLC. (AGN) traded down €0.79 ($0.92) on Monday, hitting €172.21 ($200.24). The stock had a trading volume of 3,251,700 shares, compared to its average volume of 2,918,937. The firm has a market cap of $57,270.00, a price-to-earnings ratio of 11.17, a P/E/G ratio of 1.09 and a beta of 1.12. Allergan PLC. has a 12 month low of €169.64 ($197.26) and a 12 month high of €256.80 ($298.60). The company has a current ratio of 1.18, a quick ratio of 1.08 and a debt-to-equity ratio of 0.40.
Allergan PLC. (NYSE:AGN) last released its quarterly earnings data on Wednesday, November 1st. The company reported €4.15 ($4.83) earnings per share for the quarter, beating the consensus estimate of €4.06 ($4.72) by €0.09 ($0.10). The business had revenue of €4.03 billion for the quarter, compared to analyst estimates of €4.04 billion. Allergan PLC. had a positive return on equity of 8.00% and a negative net margin of 47.27%. Allergan PLC.’s revenue was up 11.4% compared to the same quarter last year. During the same period last year, the firm posted $3.32 earnings per share. equities analysts anticipate that Allergan PLC. will post 16.28 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 15th. Investors of record on Friday, November 17th will be paid a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 1.63%. The ex-dividend date is Thursday, November 16th. Allergan PLC.’s dividend payout ratio (DPR) is presently -12.39%.
Allergan PLC. announced that its board has authorized a stock repurchase plan on Monday, September 25th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 2.8% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s leadership believes its stock is undervalued.
WARNING: “Retirement Systems of Alabama Has $55.58 Million Stake in Allergan PLC. (AGN)” was first reported by Markets Daily and is owned by of Markets Daily. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://www.themarketsdaily.com/2017/11/13/retirement-systems-of-alabama-has-55-58-million-stake-in-allergan-plc-agn.html.
A number of equities research analysts recently weighed in on AGN shares. Citigroup Inc. restated a “buy” rating and issued a $280.00 price target on shares of Allergan PLC. in a research note on Wednesday, September 20th. Piper Jaffray Companies set a $227.00 price target on Allergan PLC. and gave the company a “hold” rating in a research note on Friday, October 6th. Deutsche Bank AG set a $251.00 price target on Allergan PLC. and gave the company a “buy” rating in a research note on Tuesday, October 17th. Royal Bank Of Canada restated a “buy” rating and issued a $285.00 price target on shares of Allergan PLC. in a research note on Wednesday, September 6th. Finally, J P Morgan Chase & Co restated a “buy” rating and issued a $275.00 price target on shares of Allergan PLC. in a research note on Monday, October 16th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and twelve have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of €246.73 ($286.90).
Allergan PLC. Profile
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, womens health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimers disease.
Receive News & Ratings for Allergan PLC. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan PLC. and related companies with MarketBeat.com's FREE daily email newsletter.